Ethylene Oxide Statistics in Allentown
16+
Lawsuits Filed
B. Braun Medical Inc.
Facility Operator
Confidential (partial resolution)
2025 Settlement Status
Yes (2025)
Defense Verdict in Related Case
Courts in Allentown, Pennsylvania
Lehigh County Court of Common Pleas
455 W Hamilton St, Allentown, PA 18101
U.S. District Court — Eastern District of Pennsylvania
601 Market St, Philadelphia, PA 19106
Hospitals & Trauma Centers in Allentown
Lehigh Valley Health Network — Cancer Center
1240 S Cedar Crest Blvd, Allentown, PA 18103
Liability Considerations in Allentown
B. Braun's Defense Strategy and Mixed Trial Outcomes
B. Braun Medical has adopted an aggressive defense posture in the Allentown EtO litigation, distinguishing itself from Sterigenics by emphasizing its lower emission volumes, investment in emission control technology, and compliance with Pennsylvania Department of Environmental Protection regulations. A defense verdict in a related B. Braun case in 2025 validated some of these arguments and gave the company a significant talking point in settlement negotiations for remaining cases.
However, the confidential settlement reached in other B. Braun EtO cases suggests that the company recognizes the litigation risk is not zero. Plaintiffs' attorneys have noted that the defense verdict case involved factual circumstances that may be distinguishable from other pending claims — particularly cases involving plaintiffs who lived in closer proximity to the facility or who were diagnosed with cancer types more strongly associated with EtO exposure in epidemiological studies.
Implications for Allentown-Area Claimants
The mixed trial outcomes in B. Braun EtO litigation underscore the importance of case selection and individual exposure assessment for Allentown-area claimants. Unlike Sterigenics — where decades of high-volume emissions and a corporate record of regulatory defiance provided strong evidence of negligence — B. Braun's defense relies on presenting itself as a responsible operator that complied with applicable regulations. Plaintiffs must therefore develop individualized evidence of their proximity to the facility, duration of exposure, and the specific causation pathway linking their cancer to EtO.
Pennsylvania's two-year statute of limitations for personal injury and the state's comparative negligence framework mean that claimants must file promptly after diagnosis and be prepared to rebut B. Braun's regulatory compliance defense. Attorneys handling these cases should obtain all available EPA modeling data and Pennsylvania DEP inspection records to build the strongest possible exposure profile for each plaintiff.